Sanofi as of June 30, 2026
Portfolio Holdings for Sanofi
Sanofi holds 10 positions in its portfolio as reported in the June 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Meiragtx Holdings (MGTX) | 30.9 | $165M | 12M | 13.51 | |
| Inhibrx Biosciences (INBX) | 20.5 | $110M | 1.2M | 94.75 | |
| Novavax Com New (NVAX) | 12.1 | $65M | 6.9M | 9.42 | |
| Anaptysbio Inc Common (ANAB) | 10.4 | $56M | 822k | 67.50 | |
| Odyssey Therapeutics Common Stock | 7.0 | $37M | 2.0M | 18.71 | |
| Agomab Therapeutics NV Sponsored Ads (AGMB) | 6.8 | $36M | 2.8M | 12.98 | |
| Maplight Therapeutics (MPLT) | 6.1 | $33M | 912k | 35.84 | |
| First Tracks Biotherapeutics Ord Shs (TRAX) | 3.1 | $17M | 822k | 20.12 | |
| Immuneering Corp Class A Com (IMRX) | 2.5 | $14M | 2.7M | 4.99 | |
| Q32 Bio (QTTB) | 0.6 | $3.1M | 244k | 12.74 |
